<DOC>
	<DOCNO>NCT00927654</DOCNO>
	<brief_summary>In study effect intra operative , prophylactic inhalation Iloprost ( Ventavis ) extracorporal circulation perioperative morbidity outcome high risk cardiac surgical patient investigate comparison placebo .</brief_summary>
	<brief_title>Iloprost High Risk Cardiac Surgical Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>write informed consent female childbearing potential : negative pregnancy test patient , male female , 18 85 year old elective openheart surgery use heartlungmachine patient increase risk suffer perioperative right heart failure , i.e. , protract surgery : multiple valvular transplant expect bypass time exceed 120 min and/or patient preoperative know pulmonary hypertension and/or patient severe heart insufficiency ( NYHA III NYHA IV ) patient able give consent pregnant nursing patient Anamnestic know hypersensitivity use drug ( Ventavis ) ingredient drug similar chemical structure blood clot disorder require treatment trauma , intracerebral bleeding apoplexy within last 3 month prior surgery primary secondary immune deficiency ( e.g. , pretreatment steroid , cytostatics ) systemic infection lung disorder impair gas exchange lung transplantation cardiac transplantation implantation LVAD ( leave ventricular assist device ) fluoride ulcus disorder plan surgery deep hypothermia cardiac arrest subconscious psychiatric disorder patient participation another clinical trial within last 30 day prior study start 30 day end study previous participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Iloprost</keyword>
	<keyword>pulmonary hypertension</keyword>
	<keyword>cardio pulmonary morbidity</keyword>
	<keyword>high risk cardiac surgical patient</keyword>
</DOC>